Candlelites

Everything from Everywhere

while the us waits china has been crispring human cancer patients since 2015 - Search

while the us waits china has been crispring human cancer patients since 2015 Searched between all the resources and sites across the web. To view the full text news click on the links searched. All links are displayed with the source site.



while the u.s. waits, china has been crispring human cancer patients since 2015


while the u.s. is just gearing up to the idea of crispring its first humans, china seems to be benefiting from the “move fast and break things” — or cut them with the crispr scissors — motto.as the wall street journal reports, china has already gene-edited 86 people using crispr-cas9 since 2015. unhindered by rules and regulations like the ones we have in america to prevent science experiments gone wrong, shanghai doctor wu shixiu has been using the technique on cancer patients.in fact, it only took a half hour one afternoon, according to the journal, for hospital administrators to sign off on dr. wu’s plans.it’s not clear if these experiments worked — though some preliminary reports suggest some of the various trials have had some success. however, this is not the first time china’s used






china, unhampered by rules, races ahead in gene-editing trials


hangzhou, china—in a hospital west of shanghai, wu shixiu since march has been trying to treat cancer patients using a promising new gene-editing tool.u.s. scientists helped devise the tool, known as crispr-cas9, which has captured global attention since a 2012 report said it can be used to edit dna. doctors haven’t been allowed to use it in human trials in america. that isn’t the case for dr. wu and others in china.in...






one cancer is linked to highest suicide risk


suicide is more common among cancer patients, but a new study suggests people suffering from lung cancer are at a higher risk than those who struggle with other forms of the disease.for the study, researchers from weill cornell medical college/new york presbyterian hospital analyzed information from a large patient database of 3,640,229 people, looking at suicide deaths for lung, prostate, breast and colorectal cancers individually. they found that over four decades, there were 6,661 suicides among cancer patients.when they compared suicides among cancer patients to the general population, the rate in patients with any kind of cancer was 60 percent higher."cancer patients are under a lot of duress and stress when they're under treatment," said study author dr. jeffrey port, a thoracic and






patients with this type of cancer are most likely to commit suicide: study


depression is common among those facing chronic life-threatening diseases, such as cancer, but according to a new study, one form of cancer is significantly associated with suicide risk. the report found that lung cancer patients are 420 times more likely to attempt suicide than a member of the general public. the study, presented at the ats…






china is racing ahead of the us in the quest to cure cancer with crispr


human embryonic stem cells. image: wikimediaon friday, a team of chinese scientists used the cutting-edge gene-editing technique crispr-cas9 on humans for the second time in history, injecting a cancer patient with modified human genes in hopes of vanquishing the disease.advertisementin the us, the first planned trials to use crispr in people still have not gotten under way. but in china, things appear to be moving relatively quickly. last fall, a team at sichuan university’s west china hospital used crispr for the first time on an adult with lung cancer. in the new trial, reported by the wall street journal, altered genes were injected into a patient with a rare type of head and neck cancer, called nasopharyngeal carcinoma, at nanjing university’s nanjing drum tower hospital. advertisemen






nhs operations: waiting times to rise in 'trade-off', boss says


patients will face longer waits for operations such as knee and hip replacements in a "trade-off" for improved care in other areas, nhs england boss simon stevens says.he said growing pressures meant he could no longer guarantee treatment in the 18-week target time.gps will also have to cut the number of patients they refer to hospital and use alternatives such as physio instead.but mr stevens said in return there would be quicker cancer and a&e care.mr stevens was unveiling a progress report on his five-year strategy for the health service, launched in 2014.he said demand was rising at a quicker rate than expected and so compromises had to be made."there is a trade-off here - we do expect there will be some marginal lengthening of waiting lists, but this will still represent a strong, qui






nhs operations: waiting times to rise in 'trade-off', boss says


patients will face longer waits for operations such as knee and hip replacements in a "trade-off" for improved care in other areas, nhs england boss simon stevens says.he said growing pressures meant he could no longer guarantee treatment in the 18-week target time.gps will also have to cut the number of patients they refer to hospital and use alternatives such as physio instead.but mr stevens said in return there would be quicker cancer and a&e care.mr stevens was unveiling a progress report on his five-year strategy for the health service, launched in 2014.he said demand was rising at a quicker rate than expected and so compromises had to be made."there is a trade-off here - we do expect there will be some marginal lengthening of waiting lists, but this will still represent a strong, qui






the artist who draws cancer patients


chemotherapy treatment for cancer can be a lengthy process, and patients often say it can be a stressful, boring, anxious and challenging time.at uclh hospital in london, the artist simon tolhurst helps to change that, by offering patients the chance to sit for a pencil portrait – and a calming chat at the same time.as portrait artist in residence, simon has drawn around 250 patients and their friends and relatives, and says it allows patients to reflect and talk – while requiring no exertion on their part.here he meets and draws lucy nicholls, who is receiving treatment for non-hodgkin lymphoma.






chinese startup infervision emerges from stealth with an ai tool for diagnosing


every year roughly 600,000 people in china die from lung cancer.already the leading cause of death in the pollution-choked and chain-smoking prone nation, the incidence of lung cancer among china’s citizens is actually going to increase to 800,000 cases per-year by 2020.the situation has gotten bad enough that china’s state media has not only been forced to report on the spread of cancer  in the country, but also lay the blame for squarely at the feet of the nation’s runaway pollution problem.it’s not just the high incidence of cancer in china that’s the problem. the issue is compounded by a lack of quality healthcare in much of the country, which means that cancers often go undetected until it’s too late.for chen kuan, the chief executive and founder of infervision, a beijing-based compan






chinese startup infervision emerges from stealth with an ai tool for diagnosing


roughly 600,000 people in china die from lung cancer every year. already the leading cause of death in the pollution-choked and chain-smoking-prone nation, the incidence of lung cancer among china’s citizens is actually going to increase to 800,000 cases per year by 2020.the situation has gotten bad enough that china’s state media has not only been forced to report on the spread of cancer in the country, but also lay the blame squarely at the feet of the nation’s runaway pollution problem.it’s not just the high incidence of cancer in china that’s the problem. the issue is compounded by a lack of quality healthcare in much of the country, which means that cancers often go undetected until it’s too late.for chen kuan, the chief executive and founder of infervision, a beijing-based company us






fda approves first drug for women with breast cancer caused by flawed inherited


u.s. regulators have approved the first drug aimed at women with advanced breast cancer caused byan inherited flawed gene.the food and drug administration on friday approved astrazeneca plc's lynparza for patients with inherited brca gene mutations who have had chemotherapy.the drug has been on the market since 2014 for ovarian cancer, and is the first in a new class of medicines called parp inhibitors to be approved for breast cancer. parp inhibitors prevent cancer cells from fixing problems in their dna.lynparza will cost $13,886 per month without insurance, according to astrazeneca. the company is offering patients financial assistance."while there is currently no cure for metastatic breast cancer, today's approval offers a new, targeted option that may help to delay disease progression






few doctors discuss cancer costs with patients, study finds


most doctors did not discuss the cost of cancer treatment with patients, spent less than two minutes on it when they did, and usually did so only after patients brought it up, a study that taped hundreds of visits at several large hospitals finds.cancer patients are three times more likely to declare bankruptcy than people without cancer are, but many doctors are not having the conversations that might help prevent this and sometimes don't know the cost themselves, the results suggest."that would not occur in any other industry i can think of" where a service or product is sold, said the study leader, dr. rahma warsame of the mayo clinic.results were released wednesday by the american society of clinical oncology and will be discussed next month at its annual meeting in chicago.the study h






bay area company gives free cannabis products to cancer patients


oakland-based jetty extracts has created a program that provides free cannabis oils to cancer patients and those in remission, as a way of giving back to the medical marijuana community.






us oks 1st drug aimed at women with inherited breast cancer


u.s. regulators have approved the first drug aimed at women with advanced breast cancer caused byan inherited flawed gene.the food and drug administration on friday approved astrazeneca plc's lynparza for patients with inherited brca gene mutations who have undergone chemotherapy.the drug has been on the market since 2014 for ovarian cancer, and is the first in a new class of medicines called parp inhibitors to be approved for breast cancer. parp inhibitors prevent cancer cells from fixing problems in their dna.lynparza will cost $13,886 per month without insurance, according to astrazeneca. the company is offering patients financial assistance."while there is currently no cure for metastatic breast cancer, today's approval offers a new, targeted option that may help to delay disease progr






in west africa, cancer patients forced abroad for treatment


dakar, senegal — christine's doctor felt a small lump in her left breast at a checkup in 2015, though she was flooded with relief when the technicians assured her they had detected nothing amiss.still in pain more than a year later, she pushed for another mammogram. the 44-year-old mother of four was then diagnosed with advanced breast cancer."it was the descent into hell," she said. "you ask, 'why, why, why?' ... i was so angry. because why in 2015 did they not see this, and why was it left for so long?"the word "cancer" is rarely spoken in senegal, synonymous with death in a country where many like christine are only diagnosed in the later stages of disease and radiation therapy can be difficult to access.cancer has become an emerging public health problem in west africa, and the lack of






fda approves lilly pill for common advanced breast cancer


u.s. regulators have approved a new medicine for treating a common type of breast cancer that has spread to other parts of the body.eli lilly’s verzenio (verr-zehn’ee-oh) was approved thursday by the food and drug administration for patients with what’s called hr-positive, her2-negative breast cancer that has worsened after hormone therapy.according to the fda, about 72 percent of patients with breast cancer have this type.the daily pill is to be used either alone, after hormone therapy and chemotherapy have stopped working, or in combination with a hormone therapy called fulvestrant.most read storiesunlimited digital access. $1 for 4 weeks.indianapolis-based eli lilly says verzenio, which is taken until cancer resumes growing, will cost $10,948 per month. it’s offering patients financial






in west africa, cancer patients forced abroad for treatment


dakar, senegal — christine's doctor felt a small lump in her left breast at a checkup in 2015, though she was flooded with relief when the technicians assured her they had detected nothing amiss.still in pain more than a year later, she pushed for another mammogram. the 44-year-old mother of four was then diagnosed with advanced breast cancer."it was the descent into hell," she said. "you ask, 'why, why, why?' ... i was so angry. because why in 2015 did they not see this, and why was it left for so long?"the word "cancer" is rarely spoken in senegal, synonymous with death in a country where many like christine are only diagnosed in the later stages of disease and radiation therapy can be difficult to access.cancer has become an emerging public health problem in west africa, and the lack of






in west africa, cancer patients forced abroad for treatment


dakar, senegal (ap) — christine’s doctor felt a small lump in her left breast at a checkup in 2015, though she was flooded with relief when the technicians assured her they had detected nothing amiss.still in pain more than a year later, she pushed for another mammogram. the 44-year-old mother of four was then diagnosed with advanced breast cancer.“it was the descent into hell,” she said. “you ask, ‘why, why, why?’ … i was so angry. because why in 2015 did they not see this, and why was it left for so long?”the word “cancer” is rarely spoken in senegal, synonymous with death in a country where many like christine are only diagnosed in the later stages of disease and radiation therapy can be difficult to access.most read storiesunlimited digital access. $1 for 4 weeks.cancer has become an e






in west africa, cancer patients forced abroad for treatment


dakar, senegal (ap) — christine’s doctor felt a small lump in her left breast at a checkup in 2015, though she was flooded with relief when the technicians assured her they had detected nothing amiss.still in pain more than a year later, she pushed for another mammogram. the 44-year-old mother of four was then diagnosed with advanced breast cancer.“it was the descent into hell,” she said. “you ask, ‘why, why, why?’ … i was so angry. because why in 2015 did they not see this, and why was it left for so long?”the word “cancer” is rarely spoken in senegal, synonymous with death in a country where many like christine are only diagnosed in the later stages of disease and radiation therapy can be difficult to access.most read storiesunlimited digital access. $1 for 4 weeks.cancer has become an e






news daily: dna cancer tests and hammond's pay plan


gene testing revolution for cancer careoffer nhs patients dna tests to pick the best cancer and rare diseases treatment, england's top doctor says.4 july 2017






news daily: dna cancer tests and hammond sticks to pay plan


gene testing revolution for cancer careoffer nhs patients dna tests to pick the best cancer and rare diseases treatment, england's top doctor says.4 july 2017






catwalk models put cancer in spotlight


cancer patients took to the catwalk as part of new york fashion week.the event was organised by say yes to hope a charity which provides support for people with advanced cancer.






gut bacteria 'boost' cancer therapy


image copyrightgetty imagesbacteria living in the murky depths of the digestive system seem to influence whether tumours shrink during cancer therapy, say french and us researchers. they tested the microbiome - the collection of microscopic species that live in us - in cancer patients.two studies, in the journal science, linked specific species and the overall diversity of the microbiome to the effectiveness of immunotherapy drugs.experts said the results were fascinating and held a lot of promise.our bodies are home to trillions of micro-organisms and the relationship between "us" and "them" goes far beyond infectious diseases. the microbiome is involved in digestion, protection from infection and regulating the immune system. both studies were on patients receiving immunotherapy, which b






gut bacteria 'boost' cancer therapy


image copyrightgetty imagesbacteria living in the murky depths of the digestive system seem to influence whether tumours shrink during cancer therapy, say french and us researchers. they tested the microbiome - the collection of microscopic species that live in us - in cancer patients.two studies, in the journal science, linked specific species and the overall diversity of the microbiome to the effectiveness of immunotherapy drugs.experts said the results were fascinating and held a lot of promise.our bodies are home to trillions of micro-organisms and the relationship between "us" and "them" goes far beyond infectious diseases. the microbiome is involved in digestion, protection from infection and regulating the immune system. both studies were on patients receiving immunotherapy, which b






tumor gene testing urged to tell if drug targets your cancer – the denver post


family photo provided by katie rosenbaum via apin this 2015 family photo, catherine “katie” rosenbaum is seen at a cancer fundraiser by swim across america. the richmond, va., woman’s endometrial cancer was successfully treated in a research study that found the immunotherapy keytruda can target certain tumors that share a particular genetic flaw.washington — colon cancer. uterine cancer. pancreatic cancer. whatever the tumor, the more gene mutations lurking inside, the better chance your immune system has to fight back.that’s the premise behind the recent approval of a landmark drug, the first cancer therapy ever cleared based on a tumor’s genetics instead of the body part it struck first. now thousands of patients with worsening cancer despite standard treatment can try this immunotherap






two more human plague cases in santa fe county bring total to three this year


all three patients were hospitalized but there have been no deaths. new mexico saw four human cases in both 2015 and 2016 with only one fatality






kite pharma shares soar 25% after cancer therapy study shows good results


an experimental gene therapy that turns a patient's own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, kite pharma inc. said tuesday.in all, 82% of patients had their cancer shrink at least by half at some point in the study.shares of santa monica-based kite soared. they were up more than 25%, at $71.31, shortly before the closing bell. kite is racing novartis ag to become the first company to win approval of the treatment, called car-t cell therapy, in the u.s. it could become the nation's first approved gene therapy.a hopeful sign: the share of patients in complete remission after six months — 36% — is barely changed from partial results released after three m






kite pharma shares soar 25% after cancer therapy study shows good results


an experimental gene therapy that turns a patient's own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, kite pharma inc. said tuesday.in all, 82% of patients had their cancer shrink at least by half at some point in the study.shares of santa monica-based kite soared. they were up more than 25%, at $71.31, shortly before the closing bell. kite is racing novartis ag to become the first company to win approval of the treatment, called car-t cell therapy, in the u.s. it could become the nation's first approved gene therapy.a hopeful sign: the share of patients in complete remission after six months — 36% — is barely changed from partial results released after three m






artificial organ may help patients' form the cancer-fighting cells they need


why it matters to you this artificial organ creates t cells that can be used to bolster our immune systems. the results could help patients more effectively wage war on cancer.with cancer being the horrendous disease that it is, we’re all for any new research that suggests how we might combat it. if said research happens to involve an artificial organ, which can be described as a “bionic thymus” — well, all the better.that’s exactly what researchers at the university of california, los angeles have been working to develop. they’ve managed to use an artificial thymus to transform blood stem cells into t cells, the white blood cells that are used to help our immune system get their fight on.“t cells are the key players that fight infections and cancer, and in the past few years there’s been






immunotherapy drug opens a new era of precision medicine for cancer


with little fanfare, the food and drug administration did something this week that it's never done before: the agency approved a single prescription drug, pembrolizumab (marketed by merck as keytruda) for treatment of solid tumors in any organ so long as the malignancy bears a specific genetic signature.in the fast-moving field of cancer treatment, the fda’s announcement marks an important milestone, close to two decades in the making. increasingly, cancer will no longer be identified, categorized and treated by the organ it inhabits, or in which it first gained its foothold. in a shift that is already underway, cancers will be known by — and treated for — the common genetic mutations that nurture and sustain them.in clinical trial evidence cited by the fda this week, pembrolizumab induced






‘how long have i got, doc?’: why many cancer patients don’t have answers


due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.        






‘how long have i got?’: why many cancer patients don’t have answers


due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.        






us envoy: china should allow nobel laureate treatment abroad


beijing (ap) — the new u.s. ambassador to beijing said wednesday that nobel peace prize laureate liu xiaobo should be allowed to receive treatment outside china after he was diagnosed with cancer while in prison for advocating democratic reforms.china should allow 61-year-old liu to seek treatment elsewhere “if it would be of help,” ambassador terry branstad told reporters at his first public appearance since arriving in beijing this week.the former six-term iowa governor appointed as the envoy to china by president donald trump did not say if he’d spoken directly with chinese authorities about the matter, emphasizing cooperation instead.“it’s important that we work together between our two countries to address these human rights issues,” branstad said.most read storiesunlimited digital ac






henna crowns: 'hair' for cancer patient


for cancer patients undergoing chemotherapy, losing their hair can be an extremely difficult and upsetting consequence. but now, there’s a new alternative to wigs and hats.abi, who is supporting the fundraising campaign stand up to cancer, explains how she faced her diagnosis and treatment.video journalist: sofia bettiza






us envoy: china should allow nobel laureate treatment abroad


beijing — the new u.s. ambassador to beijing said wednesday that nobel peace prize laureate liu xiaobo should be allowed to receive treatment outside china after he was diagnosed with cancer while in prison for advocating democratic reforms.china should allow 61-year-old liu to seek treatment elsewhere "if it would be of help," ambassador terry branstad told reporters at his first public appearance since arriving in beijing this week.the former six-term iowa governor appointed as the envoy to china by president donald trump did not say if he'd spoken directly with chinese authorities about the matter, emphasizing cooperation instead."it's important that we work together between our two countries to address these human rights issues," branstad said.liu was given a medical parole and hospita






thousands living with advanced cancer, says macmillan


image copyrightfamily photoimage caption emma young has three children thousands of people in england who have the most advanced cancers are surviving for several years after diagnosis, according to new research. macmillan cancer support said it was down to new treatments but warned that living longer with advanced cancer can bring its own difficulties.emma young, 39, was diagnosed with breast and bone cancer at 35."the not-knowing is the hardest, from scan to scan you don't know how it will be," she says."from the time you have the scan until you get the results is really hard - 'scanziety' is what we call it." her diagnosis in may 2014 was delayed after doctors misdiagnosed her symptoms. days after being told she had breast cancer she was told it had spread to her bones. stage 4 cancer i






most religious groups come out against trump refugee order


rabbi joel mosbacher had just finished the morning's shabbat service when he got an urgent message: rabbis were needed at new york's kennedy airport. people were being detained under president donald trump's sharp travel restrictions on refugees. would he come pray?by sundown, mosbacher was part a group of rabbis at the airport, playing guitar and conducting a havdalah service marking the end of the sabbath. about 2,000 people gathered to rally against the new policy."we know what it's like to be the stranger," said mosbacher, a reform rabbi at temple shaaray tefila, noting that jewish refugees were at times turned away from the u.s. "as a person of faith, it was so important to be there."from pulpits to sidewalk vigils, clergy have been part of a religious outpouring against trump's plan